PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
72.63%
EBIT growth 1.25-1.5x WEED.TO's 58.76%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
72.63%
Operating income growth 1.25-1.5x WEED.TO's 58.76%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
73.70%
Net income growth 1.25-1.5x WEED.TO's 58.76%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
80.46%
EPS growth 1.25-1.5x WEED.TO's 58.82%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
80.46%
Diluted EPS growth 1.25-1.5x WEED.TO's 58.82%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
33.82%
Share count expansion well above WEED.TO's 0.20%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
33.82%
Diluted share count expanding well above WEED.TO's 0.20%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
94.18%
OCF growth 1.25-1.5x WEED.TO's 70.67%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
94.18%
FCF growth 1.25-1.5x WEED.TO's 70.67%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-35.39%
Firm’s AR is declining while WEED.TO shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-4.88%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-31.47%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-72.63%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.